Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Traws Pharma (TRAW) Other Working Capital Changes (2016 - 2025)

Traws Pharma's Other Working Capital Changes history spans 14 years, with the latest figure at -$2.2 million for Q4 2025.

  • Quarterly results put Other Working Capital Changes at -$2.2 million for Q4 2025, down 3751.79% from a year ago — trailing twelve months through Dec 2025 was -$859000.0 (down 187.21% YoY), and the annual figure for FY2025 was -$2.8 million, down 12397.32%.
  • Other Working Capital Changes for Q4 2025 was -$2.2 million at Traws Pharma, down from $23058.0 in the prior quarter.
  • In the past five years, Other Working Capital Changes ranged from a high of $1.4 million in Q4 2023 to a low of -$2.2 million in Q4 2025.
  • The 5-year median for Other Working Capital Changes is $18461.0 (2021), against an average of -$58683.1.
  • The sharpest move saw Other Working Capital Changes surged 26656.76% in 2022, then tumbled 3751.79% in 2025.
  • Year by year, Other Working Capital Changes stood at -$33000.0 in 2021, then tumbled by 2942.42% to -$1.0 million in 2022, then soared by 242.43% to $1.4 million in 2023, then tumbled by 103.92% to -$56000.0 in 2024, then tumbled by 3751.79% to -$2.2 million in 2025.
  • According to Business Quant data, Other Working Capital Changes over the past three periods came in at -$2.2 million, $23058.0, and $23057.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.